Press release (regulatory)
Skanska has signed a contract with Regeneron Pharmaceuticals Inc. to construct the interior fit-out of their office space in Sleepy Hollow, New York, USA. The contract is worth USD 32 M, about SEK 310 M, which will be included in the US order bookings for the first quarter 2020.
The project includes the interior fit-out of an approximately 18,500-square-meter space. The scope of work includes upgrades to the existing building, new mechanical distribution, ceilings, LED lighting, flooring and glass front offices.
Construction began in March of 2020 and is scheduled for completion in July 2021.
Skanska is one of the leading construction and development companies in USA, specializing in building construction, civil infrastructure and developing commercial properties in select U.S. markets. Skanska USA had sales of SEK 74 billion and about 7,900 employees in its operations in 2019.
For further information please contact:
Pamela Monastra, Senior Vice President, Skanska USA, tel +1 770 639 4504
Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found atwww.skanska.com.
Are you a journalist looking for information about Skanska or have questions about our operations? Our Media Relations team can help with press inquiries, interviews, background information and access to relevant resources.

Jacob Birkeland
Head of Media Relations & Public Affairs

Andreas Joons
Media Relations Manager

Olof Rundgren
Media Relations Manager